NCT07690540
- Conditions
- Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +11 more
- Locations
-
- European Institute of Oncology Milan, Italy
Clinical trial condition
Immune Checkpoint Inhibitors
Explore clinical trials studying Immune Checkpoint Inhibitors. Study availability and eligibility vary by location and protocol.
27 public trials
11 recruiting studies
Immune Checkpoint Inhibitors trial results
NCT06960577
- Conditions
- Cisplatin, Doxorubicin, Female Urogenital Diseases, +14 more
- Locations
-
- Research Site Chermside, Australia
- Research Site Elizabeth Vale, Australia
- Research Site Heidelberg, Australia
- Research Site Hong Kong, Australia
NCT06576921
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
- Locations
-
- The fourth hospital of Hebei Medical University Shijiazhuang, Heibei Province, China
- Department of Digestive surgery, Xijing Hospital of Digestive Diseases, Air Force Medical University, Xi' an, China Xi'an, Shaanxi, China
- Department of General Surgery, Tangdu Hospital, Air Force Medical University Xi'an, Shaanxi, China
- Department of General Surgery, The 986th Military Hospital, Air Force Medical University Xi'an, Shaanxi, China
NCT06647134
- Conditions
- Arthritis, Connective Tissue Diseases, Immune Checkpoint Inhibitors, +6 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
NCT07512518
- Conditions
- Brain Diseases, Central Nervous System Diseases, Central Nervous System Infections, +16 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT04572451
- Conditions
- Antineoplastic Agents, Antineoplastic Agents, Immunological, Immune Checkpoint Inhibitors, +15 more
- Locations
-
- University of Chicago Medical Center Chicago, Illinois, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
NCT07034326
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin, China
NCT05813418
- Conditions
- Immune Checkpoint Inhibitors, Immune-related Adverse Event, Immunotherapy, +1 more
- Locations
-
- CHU Amiens Picardie Amiens, Picardie, France
NCT06975384
- Conditions
- Cancer, Treatment-Related, Disease Attributes, Disease Progression, +17 more
- Locations
-
- Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China
NCT05477979
- Conditions
- Behavior, Behavioral Symptoms, Cancer, Treatment-Related, +16 more
- Locations
-
- Department of Oncology, The Second Xiangya Hospital, Central South University Changsha, Hunan, China